tiprankstipranks
AstraZeneca PLC (MX:AZN1N)
:AZN1N
Mexico Market
AZN1N
AstraZeneca
RESEARCH TOOLSreports

AstraZeneca (AZN1N) Ratios

0 Followers

AstraZeneca Ratios

MX:AZN1N's free cash flow for Q2 2026 was $0.74. For the 2026 fiscal year, MX:AZN1N's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.89 0.94 0.93 0.81 0.86
Quick Ratio
 0.67 0.72 0.74 0.64 0.68
Cash Ratio
 0.16 0.19 0.20 0.19 0.23
Solvency Ratio
 0.25 0.24 0.19 0.18 0.14
Operating Cash Flow Ratio
 0.43 0.48 0.43 0.34 0.37
Short-Term Operating Cash Flow Coverage
 2.19 4.70 5.50 2.11 1.88
Net Current Asset Value
$ -37.69B$ -36.63B$ -37.36B$ -37.11B$ -36.83B
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.26 0.29 0.28 0.30
Debt-to-Equity Ratio
 0.64 0.61 0.74 0.73 0.79
Debt-to-Capital Ratio
 0.39 0.38 0.42 0.42 0.44
Long-Term Debt-to-Capital Ratio
 0.32 0.34 0.39 0.36 0.38
Financial Leverage Ratio
 2.30 2.34 2.55 2.58 2.61
Debt Service Coverage Ratio
 2.29 3.68 3.76 2.02 1.54
Interest Coverage Ratio
 7.97 8.11 9.19 8.31 5.69
Debt to Market Cap
 0.12 0.10 0.14 0.13 0.13
Interest Debt Per Share
 22.02 20.20 20.31 18.92 19.40
Net Debt to EBITDA
 1.34 1.21 1.66 1.71 2.66
Profitability Margins
Gross Profit Margin
79.27%81.90%74.98%73.95%63.36%
EBIT Margin
23.02%24.00%18.70%17.56%7.65%
EBITDA Margin
33.37%33.76%28.06%28.33%19.50%
Operating Profit Margin
22.69%23.40%23.65%20.54%11.41%
Pretax Profit Margin
20.51%21.11%16.07%15.06%5.64%
Net Profit Margin
17.02%17.41%13.01%13.00%7.41%
Continuous Operations Profit Margin
17.03%17.42%13.02%13.01%7.42%
Net Income Per EBT
82.99%82.45%80.95%86.32%131.47%
EBT Per EBIT
90.42%90.24%67.96%73.31%49.43%
Return on Assets (ROA)
8.96%8.96%6.62%5.99%3.40%
Return on Equity (ROE)
21.68%21.01%16.89%15.47%8.86%
Return on Capital Employed (ROCE)
16.41%16.47%16.44%13.56%7.19%
Return on Invested Capital (ROIC)
12.69%13.04%12.90%10.94%6.67%
Return on Tangible Assets
18.23%18.60%15.03%14.09%8.78%
Earnings Yield
4.12%3.56%3.39%2.87%1.56%
Efficiency Ratios
Receivables Turnover
 3.81 3.59 4.05 3.94 4.81
Payables Turnover
 0.55 0.42 3.64 3.71 6.36
Inventory Turnover
 1.82 1.62 2.51 2.26 3.45
Fixed Asset Turnover
 3.74 4.00 4.55 4.44 4.68
Asset Turnover
 0.53 0.51 0.51 0.46 0.46
Working Capital Turnover Ratio
 -18.67 -29.67 -13.64 -9.91 -563.30
Cash Conversion Cycle
 -365.28 -541.16 135.45 156.22 124.19
Days of Sales Outstanding
 95.74 101.54 90.18 92.72 75.82
Days of Inventory Outstanding
 200.22 225.08 145.57 161.76 105.79
Days of Payables Outstanding
 661.24 867.79 100.31 98.26 57.41
Operating Cycle
 295.96 326.62 235.75 254.49 181.60
Cash Flow Ratios
Operating Cash Flow Per Share
 8.86 9.40 7.65 6.62 6.34
Free Cash Flow Per Share
 5.44 5.59 4.69 4.20 4.68
CapEx Per Share
 3.42 3.81 2.96 2.42 1.66
Free Cash Flow to Operating Cash Flow
 0.61 0.59 0.61 0.63 0.74
Dividend Paid and CapEx Coverage Ratio
 1.35 1.34 1.29 1.25 1.41
Capital Expenditure Coverage Ratio
 2.59 2.47 2.59 2.74 3.81
Operating Cash Flow Coverage Ratio
 0.42 0.49 0.39 0.36 0.34
Operating Cash Flow to Sales Ratio
 0.22 0.25 0.22 0.22 0.22
Free Cash Flow Yield
3.33%3.01%3.58%3.12%3.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.33 28.11 29.47 34.81 63.97
Price-to-Sales (P/S) Ratio
 4.13 4.90 3.83 4.52 4.74
Price-to-Book (P/B) Ratio
 5.01 5.91 4.98 5.38 5.67
Price-to-Free Cash Flow (P/FCF) Ratio
 30.02 33.17 27.90 32.10 29.00
Price-to-Operating Cash Flow Ratio
 18.43 19.73 17.11 20.37 21.40
Price-to-Earnings Growth (PEG) Ratio
 1.04 0.58 2.17 0.41 0.02
Price-to-Fair Value
 5.01 5.91 4.98 5.38 5.67
Enterprise Value Multiple
 13.72 15.71 15.32 17.69 26.98
Enterprise Value
 280.56B 311.51B 227.63B 233.39B 232.85B
EV to EBITDA
 13.72 15.71 15.32 17.69 26.98
EV to Sales
 4.58 5.30 4.30 5.01 5.26
EV to Free Cash Flow
 33.27 35.93 31.29 35.54 32.18
EV to Operating Cash Flow
 20.42 21.37 19.19 22.56 23.74
Tangible Book Value Per Share
 -5.53 -6.69 -11.18 -12.04 -14.26
Shareholders’ Equity Per Share
 32.60 31.40 26.31 25.06 23.93
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.19 0.14 -0.32
Revenue Per Share
 39.51 37.90 34.16 29.82 28.59
Net Income Per Share
 6.73 6.60 4.44 3.88 2.12
Tax Burden
 0.83 0.82 0.81 0.86 1.31
Interest Burden
 0.89 0.88 0.86 0.86 0.74
Research & Development to Revenue
 0.24 0.24 0.23 0.23 0.22
SG&A to Revenue
 0.33 0.35 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.01 0.01
Income Quality
 1.19 1.18 1.36 1.50 3.92
Currency in USD